To further elucidate the role for CD36 on cancer cells to engage with ECM components, adhesion assays were performed on collagen I, collagen IV, laminin and fibronectin, all of which are in high abundance in the ECM of tumors [48] and all are documented ligands for CD36 [42]. Here, CD36 is linked to cancer.